NCT07221474 2026-03-12
INTerpath-13
Merck Sharp & Dohme LLC
Phase 2 Recruiting
Clinical Trials
6 trialsNCT07360132 2026-01-22
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT03542461 2022-10-03
EDEN
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3 Unknown
NCT05243355 2022-02-17
Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Qilu Hospital of Shandong University
Phase 2 Unknown
NCT03319316 2022-01-10
SOLUTION
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT01763788 2019-10-25
A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Eli Lilly and Company
Phase 1/2 Completed